Ποια είναι η τιμή για Caliber Imaging & Diagnostics, Inc. (LCDX)

Η τιμή για Caliber Imaging & Diagnostics, Inc. (LCDX) είναι $0.0006

Ποια είναι η κεφαλαιοποίηση αγοράς για Caliber Imaging & Diagnostics, Inc. (LCDX)

Η κεφαλαιοποίηση αγοράς για Caliber Imaging & Diagnostics, Inc. (LCDX) είναι $5.10K

Caliber Imaging & Diagnostics, Inc. (LCDX) Τιμή και Κεφαλαιοποίηση Αγοράς

Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution. Their product line features the VivaScope 1500, a reflectance confocal imaging system that empowers medical practitioners and scientists to capture detailed confocal images depicting the cellular architecture of living tissue. They also provide the VivaScope 3000, a handheld in vivo reflectance confocal microscope tailored for dermatological imaging. Complementing its hardware, the firm offers VivaScan software, which streamlines patient scheduling, facilitates multi-lesion imaging during appointments, and assists with image review and reporting. Additionally, they supply VivaNet, a sophisticated digital telepathology system. Initially established as Lucid, Inc. in 1991, the company rebranded as Caliber Imaging & Diagnostics, Inc. in August 2012 and is headquartered in Andover, Massachusetts.

Η τιμή για LCDX	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$632,840 $5.10K	NVDA	$5.383T	+105,473,346,544.31%
$519,991 $5.10K	AAPL	$4.423T	+86,665,190,519.69%
$489,072 $5.10K	GOOG	$4.160T	+81,511,941,849.67%
$430,641 $5.10K	MSFT	$3.663T	+71,773,529,306.90%
$339,878 $5.10K	AMZN	$2.891T	+56,646,333,705.33%

Η τιμή για LCDX

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$632,840 $5.10K